Ji Luo

10PUBLICATIONS
44CO-AUTHORS
Molecular targetsGene and molecular therapyCancer cell biologyCancer geneticsSoftware quality, processes and metrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 12, 2024
Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppression.

Sara Zahraeifard, Zhiguang Xiao, Jae Young So

|May 14, 2024
Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in <i>KRAS</i>- and <i>BRAF</i>-mutant cancer cells.

Haibo Zhang, Abigail Read, Christophe Cataisson

|Apr 23, 2024
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

Perla Pucci, Liam C Lee, Miaojun Han

|Jun 20, 2023
A Nonconserved Histidine Residue on KRAS Drives Paralog Selectivity of the KRASG12D Inhibitor MRTX1133.

Miles A Keats, John J W Han, Yeon-Hwa Lee

|Jun 21, 2022
Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence.

Vanesa C Sanchez, Howard H Yang, Alayna Craig-Lucas

|May 16, 2022
Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.

Sanju Sinha, Karina Barbosa, Kuoyuan Cheng

Pageof 2

Frequent Collaborators

3 joint publications

Howard Yang

2 joint publications

Maxwell Lee

2 joint publications

Stuart H Yuspa

2 joint publications

Aniruddha J Deshpande